[1] MARTHE M. VANDEPUTTE. Synthesis, Chemical Characterization, and μ-Opioid Receptor Activity Assessment of the Emerging Group of “Nitazene” 2-Benzylbenzimidazole Synthetic Opioids.[J]. ACS Chemical Neuroscience, 2021. DOI:
10.22541/au.160520665.59016513/v2[2] ISTVÁN UJVÁRY*. DARK Classics in Chemical Neuroscience: Etonitazene and Related Benzimidazoles[J]. ACS Chemical Neuroscience, 2021, 12 7: 1072-1092. DOI:
10.1021/acschemneuro.1c00037[3] KYOKO HATAOKA. Evaluation of rewarding effects of nitazene analogs: results from conditioned place preference tests and in vivo microdialysis experiments in mice.[J]. Journal of Toxicological Sciences, 2025, 50 1: 33-43. DOI:
10.2131/jts.50.33[4] MENG-HUA M. TSAI, LEI SHI* In Vitro Functional Profiling of Fentanyl and Nitazene Analogs at the μ-Opioid Receptor Reveals High Efficacy for Gi Protein Signaling[J]. ACS Chemical Neuroscience, 2024, 15 4: 854-867. DOI:
10.1021/acschemneuro.3c00750[5] GRANT C GLATFELTER. Alkoxy chain length governs the potency of 2-benzylbenzimidazole “nitazene” opioids associated with human overdose.[J]. Psychopharmacology, 2023: 2573-2584. DOI:
10.1007/s00213-023-06451-2